Summary
HCA Healthcare, Inc. (HCA) reported a strong third quarter of 2025, with revenues increasing by 9.6% to $19.161 billion and net income attributable to HCA Healthcare, Inc. rising by 29.4% to $1.643 billion, or $6.96 per diluted share. This robust performance was driven by a combination of increased patient volumes and higher revenue per equivalent admission. The company has also seen significant improvements in operational efficiencies, particularly in managing labor costs. Despite positive operational results, HCA highlighted several significant policy and economic uncertainties that could impact future performance. These include potential reductions in Medicare reimbursement due to the "One Big Beautiful Bill Act" (OBBBA), the expiration of enhanced premium tax credits (EPTCs) at the end of 2025, ongoing federal government shutdowns, and continued inflationary pressures on operating expenses. HCA is actively engaged in advocacy and implementing resiliency plans to mitigate these potential headwinds. Investors should monitor the evolving regulatory landscape and the company's ability to adapt to these changes.
Financial Highlights
45 data points| Revenue | $19.16B |
| Operating Expenses | $16.74B |
| Interest Expense | $561.00M |
| Net Income | $1.64B |
| EPS (Basic) | $7.05 |
| EPS (Diluted) | $6.96 |
| Shares Outstanding (Basic) | 232.89M |
| Shares Outstanding (Diluted) | 236.18M |
Key Highlights
- 1Q3 2025 revenue increased 9.6% year-over-year to $19.161 billion.
- 2Q3 2025 net income attributable to HCA Healthcare, Inc. grew 29.4% to $1.643 billion, or $6.96 per diluted share.
- 3Revenue per equivalent admission increased by 6.1% on a consolidated basis and 6.6% on a same-facility basis, indicating improved pricing power and/or payer mix.
- 4Consolidated equivalent admissions increased by 3.2%, showing growth in overall patient volume.
- 5Salaries and benefits as a percentage of revenue decreased to 43.6% from 45.0% in the prior year, reflecting successful labor management initiatives.
- 6Cash flow from operating activities increased significantly by $2.322 billion for the first nine months of 2025, largely due to higher net income and a deferral of income tax payments.
- 7The company faces significant policy risks, including potential Medicare reimbursement cuts from the OBBBA and the expiration of EPTCs, which could impact future revenue.